Merck & Co.’ Inc.’s stock MRK rose 2% premarket Tuesday, after the company reported positive results for a new formulation ... for the first-line treatment of adult patients with metastatic non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback